-45.28 (-0.71%)
-2.75 (-0.78%)| 5-Day | 113,251 |
| 10-Day | 119,476 |
| 30-Day | 133,168 |
| 5-Day | 113,251 |
| 10-Day | 119,476 |
| 30-Day | 133,168 |
-2.65 (-0.75%)| 5-Day | 1,173,359 |
| 10-Day | 1,161,526 |
| 30-Day | 1,060,870 |
| 5-Day | 1,173,359 |
| 10-Day | 1,161,526 |
| 30-Day | 1,060,870 |
COLLAPSE ALL| Days | BSE | NSE |
| 30 | 332.59 | 332.95 |
| 50 | 328.16 | 328.44 |
| 150 | 308.43 | 308.56 |
| 200 | 310.94 | 311.06 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Cipla
| (Sep '11) Quarterly |
(Mar '11) Yearly |
|
| Net Sales | 1778.02 | 6123.84 |
| Other Income | 24.31 | 79.43 |
| PBDIT | 461.92 | 1906.45 |
| Net Profit | 308.97 | 967.12 |
| Total Share Capital | 160.58 |
| Net Worth | 6612.95 |
| Total Debt | 441.39 |
| Net Block | 2868.02 |
| Investments | 570.28 |
| Net Current Assets | 3362.97 |
| Total Assets | 7054.34 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 541.30 | -0.12 | 565.75 | 404.00 | 56,056.05 |
| Cipla | 349.00 | -0.78 | 359.00 | 273.60 | 28,021.96 |
| Dr Reddys Labs | 1619.85 | -1.19 | 1716.00 | 1387.00 | 27,463.59 |
| Lupin | 458.80 | -2.90 | 492.00 | 363.00 | 20,491.02 |
| Ranbaxy Labs | 443.30 | -1.83 | 570.00 | 366.50 | 18,708.66 |
| More » | |||||
| Sep' 11 | Jun' 11 | Mar' 11 | Dec' 10 | |
| Promoter | 36.80 | 36.80 | 36.80 | 36.80 |
| FII | 13.57 | 14.73 | 15.26 | 15.41 |
| DII | 19.86 | 19.08 | 18.59 | 18.66 |
| Others | 29.77 | 29.39 | 29.35 | 29.13 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| HDFC Equity Fund (G) | 6,570,646 |
| ICICI Prudential Focused Bluechip Equity Fund (G) | 6,484,321 |
| ICICI Prudential Dynamic Plan (G) | 5,527,783 |
| HDFC Top 200 Fund (G) | 5,308,924 |
|
| Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
Bigg Boss Season 5
| History India | Davos
| Uninor | Aurobindo Pharma | Vodafone Essar | Indian Space Research Organisation | Suzlon Energy | Etisalat | Bonus share | Consumer Confidence Index | Lucas Papademos | DLF Limited